September 30, 2020 - Page 11 of 17

NASDAQ Companies - September 30, 2020

Cassava Sciences’ Phase 2b Clinical Results in Alzheimer’s Selected as Late-Breaking News at CTAD 2020

AUSTIN, Texas, Sept. 30, 2020 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biopharmaceutical company focused on Alzheimer’s […]

NASDAQ Companies - September 30, 2020

Cowen Grows Special Situations Group With Addition of Industry Veteran Kenneth Garnett

NEW YORK, Sept. 30, 2020 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) today announced that Kenneth Garnett […]

Canadian Stock Exchange News - September 30, 2020

FenixOro Launches Drill Program at Abriaqui

TORONTO, Sept. 30, 2020 (GLOBE NEWSWIRE) — FenixOro Gold Corp (CSE:FENX, OTCQB:FDVXF, Frankfurt: 8FD) is pleased to detail the objectives […]

Canadian Stock Exchange News - September 30, 2020

TILT Holdings Announces Upcoming Conference Participation

PHOENIX, Sept. 30, 2020 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (CSE: TILT) (OTCQB: TLLTF), a provider […]

NASDAQ Companies - September 30, 2020

America First Multifamily Investors, L.P. Announces Issuance of Secured Notes to Mizuho

OMAHA, Neb., Sept. 30, 2020 (GLOBE NEWSWIRE) — On September 30, 2020, America First Multifamily Investors, L.P. (the “Partnership”), announced […]

NASDAQ Companies - September 30, 2020

Genetron Health Receives U.S. FDA Breakthrough Device Designation for its Blood-based NGS Test for Early Detection of Hepatocellular Carcinoma

BEIJING and GAITHERSBURG, Md., Sept. 30, 2020 (GLOBE NEWSWIRE) — Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), […]

NASDAQ Companies - September 30, 2020

Outlook Therapeutics Provides Update on Progress Towards First Approved Ophthalmic Formulation of Bevacizumab-vikg for Advanced Macular Degeneration

MONMOUTH JUNCTION, N.J., Sept. 30, 2020 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) is a late clinical-stage biopharmaceutical company […]